Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin

ClinicalTrials.gov ID: NCT04770532

Public ClinicalTrials.gov record NCT04770532. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 26-week Trial Comparing the Effect and Safety of Once Weekly Insulin Icodec and Once Daily Insulin Degludec, Both With or Without Non-insulin Anti-diabetic Drugs, in Subjects With Type 2 Diabetes Treated With Basal Insulin

Study identification

NCT ID
NCT04770532
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
526 participants

Conditions and interventions

Interventions

  • Insulin Icodec Drug
  • Insulin degludec Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2021
Primary completion
Jan 26, 2022
Completion
Feb 28, 2022
Last update posted
Dec 14, 2025

2021 – 2022

United States locations

U.S. sites
38
U.S. states
13
U.S. cities
35
Facility City State ZIP Site status
American Clinical Trials Buena Park California 90620
Cedars-Sinai Medical Group Encino California 91436
Valley Research Fresno California 93720
Diabetes/Lipid Mgmt & Res Ctr Huntington Beach California 92648
Scripps Whittier Diabetes Inst La Jolla California 92037
Clinical Trials Research_Sacramento Lincoln California 95648
Valley Clinical Trials, Inc. Northridge California 91325
Desert Oasis Hlthcr Med Group Palm Springs California 92262
Diablo Clinical Research, Inc. Walnut Creek California 94598
South Broward Research LLC Miramar Florida 33027
Renstar Medical Research Ocala Florida 34470
Atlanta Diabetes Associates Atlanta Georgia 30318
Endo Res Solutions Inc Roswell Georgia 30076
Velocity Clin. Res Valparaiso Valparaiso Indiana 46383
Four Rivers Clinical Research Inc Paducah Kentucky 42001
New Orleans Center for Clinical Research New Orleans Louisiana 70119
Ileana J Tandron APMC Slidell Louisiana 70461-4231
Endo And Metab Cons Rockville Maryland 20852
Brigham & Women's Hospital Boston Massachusetts 02115-5804
MassResearch, LLC Waltham Massachusetts 02453
Palm Research Center Inc. Las Vegas Nevada 89148
AMC Community Endocrinology Albany New York 12203
Northport VA Med Ctr Northport Northport New York 11768
Mountain Diabetes & Endocrine Center Asheville North Carolina 28803
PharmQuest Life Sciences LLC Greensboro North Carolina 27408
Accellacare Wilmington North Carolina 28401
Amarillo Med Spec LLP Amarillo Texas 79106
Osvaldo A. Brusco MD PA Corpus Christi Texas 78414
Thyroid, Endocrinology, and Diabetes, PA Dallas Texas 75208
Baylr Sctt White Rs Inst, Endo Dallas Texas 75226
Velocity Clinical Res-Dallas Dallas Texas 75230
UT Southwestern Med Cntr Dallas Texas 75390-9302
Diabetes and Thyroid Ctr of FW Fort Worth Texas 76132
PlanIt Research, PLLC Houston Texas 77079
Sun Research Institute San Antonio Texas 78215
Simcare Medical Research, LLC Sugar Land Texas 77478
Hillcrest Family Health Center Waco Texas 76708
Capital Clin Res Ctr,LLC Olympia Washington 98502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04770532, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 14, 2025 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04770532 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →